First Republic Investment Management, Inc. Biomarin Pharmaceutical Inc Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

A detailed history of First Republic Investment Management, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 67,207 shares of BMRN stock, worth $4.26 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

67,207

Holding current value

$4.26 Million

% of portfolio

0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$85.07 - $94.48 $5.72 Million - $6.35 Million	67,207 New	67,207 $5.95 Million
Q1 2023 May 11, 2023	BUY	$87.74 - $117.27 $148,368 - $198,303	1,691 Added 12.94%	14,764 $1.44 Million
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $98,815 - $132,637	1,221 Added 10.3%	13,073 $1.35 Million
Q3 2022 Nov 03, 2022	BUY	$82.16 - $96.94 $121,103 - $142,889	1,474 Added 14.2%	11,852 $1.01 Million
Q2 2022 Aug 16, 2022	SELL	$71.48 - $86.85 $222,803 - $270,711	-3,117 Reduced 23.1%	10,378 $860,000
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $171,289 - $213,743	2,306 Added 20.61%	13,495 $1.04 Million
Q4 2021 Feb 09, 2022	SELL	$71.72 - $91.47 $154,628 - $197,209	-2,156 Reduced 16.16%	11,189 $989,000
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $227,375 - $259,914	3,041 Added 29.51%	13,345 $1.03 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $151 - $169	2 Added 0.02%	10,304 $860,000
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $152,822 - $185,461	-2,045 Reduced 16.56%	10,302 $778,000
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $115,740 - $143,778	-1,594 Reduced 11.43%	12,347 $1.08 Million
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $99,539 - $181,476	1,385 Added 11.03%	13,941 $1.06 Million
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $207,705 - $324,338	2,611 Added 26.25%	12,556 $1.55 Million
Q1 2020 May 13, 2020	BUY	$71.37 - $96.85 $86,000 - $116,704	1,205 Added 13.79%	9,945 $840,000
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $65,941 - $88,615	1,026 Added 13.3%	8,740 $739,000
Q3 2019 Nov 08, 2019	BUY	$67.4 - $85.11 $59,312 - $74,896	880 Added 12.88%	7,714 $520,000
Q2 2019 Aug 07, 2019	BUY	$80.35 - $93.9 $71,270 - $83,289	887 Added 14.92%	6,834 $585,000
Q1 2019 Apr 30, 2019	BUY	$84.2 - $98.62 $149,876 - $175,543	1,780 Added 42.72%	5,947 $528,000
Q4 2018 Feb 12, 2019	SELL	$80.14 - $106.07 $575,725 - $762,006	-7,184 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $674,721 - $759,492	7,184 New	7,184 $696,000
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $27,895 - $36,344	-367 Reduced 5.16%	6,750 $636,000
Q1 2018 May 10, 2018	BUY	$77.67 - $92.63 $349,748 - $417,112	4,503 Added 172.26%	7,117 $577,000
Q4 2017 Feb 09, 2018	SELL	$80.76 - $95.13 $191,320 - $225,362	-2,369 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $190,941 - $224,936	2,369	2,369 $220,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account

First Republic Investment Management, Inc. Biomarin Pharmaceutical Inc Transaction History